Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful?

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 6, 2014, Pages

  Tang, Ting Seng ^a   Bieber, Thomas ^a,b   Williams, Hywel C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

atopic dermatitis; atopic eczema; Eczema; induction of remission; long term management; subclinical inflammation

Indexed keywords

ALCLOMETASONE; BETAMETHASONE VALERATE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; FLUTICASONE; FLUTICASONE PROPIONATE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; METHYLPREDNISOLONE ACEPONATE; PIMECROLIMUS; PSORALEN; TACROLIMUS; CYTOKINE;

ARTICLE; ATOPIC DERMATITIS; CYTOKINE PRODUCTION; DISEASE CONTROL; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; HUMAN; INFLAMMATION; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; MAINTENANCE THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PUVA; RELAPSE; REMISSION; RISK FACTOR; SKIN BARRIER DYSFUNCTION; SKIN DISEASE; SUBCLINICAL INFLAMMATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ASYMPTOMATIC DISEASE; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE CLEARANCE; EVIDENCE BASED PRACTICE; HIGH RISK PATIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN ATROPHY; SKIN DEFECT; SKIN PERMEABILITY; SYSTEMIC THERAPY; TIME TO TREATMENT; TOPICAL TREATMENT;

ATOPIC DERMATITIS; ATOPIC ECZEMA; ECZEMA; INDUCTION OF REMISSION; LONG-TERM MANAGEMENT; SUBCLINICAL INFLAMMATION;

ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; PHOTOTHERAPY; REMISSION INDUCTION; SKIN; TREATMENT OUTCOME;

EID: 84901809097     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.12.1079     Document Type: Article

References (68)

1. Nankervis H, Samuels HJ, Delamere F, Thomas K, Williams HC. The Global Resource of Eczema Trials. Centre of Evidence Based Dermatology. Available at: http://www.greatdatabase.org.uk. Accessed October 18, 2013.
2. T. Bieber, M. Cork, and S. Reitamo Atopic dermatitis: A candidate for disease-modifying strategy Allergy 67 2012 969 975
3. J. Schmitt, L. von Kobyletzki, A. Svensson, and C. Apfelbacher Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials Br J Dermatol 164 2011 415 428
4. CHMP/EWP/18463/2006. Guideline on the development of new medicinal products for the treatment of ulcerative colitis. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003266.pdf.
5. H.C. Williams Preventing eczema flares with topical corticosteroids or tacrolimus: which is best? Br J Dermatol 164 2011 231 233
6. D.M. Ashcroft, L.C. Chen, R. Garside, K. Stein, and H.C. Williams Topical pimecrolimus for eczema Cochrane Database Syst Rev 4 2007 CD005500
7. A. Wollenberg, S. Kraft, D. Hanau, and T. Bieber Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema J Invest Dermatol 106 1996 446 453 (Pubitemid 26117582)
8. C. Bangert, B.E. Strober, M. Cork, J.P. Ortonne, T. Luger, and T. Bieber et al. Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: A randomized controlled trial Dermatology 222 2011 36 48
9. M. Caproni, D. Torchia, E. Antiga, M. Terranova, W. Volpi, and E. del Bianco et al. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: An immunohistochemical study Br J Dermatol 156 2007 312 319 (Pubitemid 46095960)
10. D. Simon, E. Vassina, S. Yousefi, E. Kozlowski, L.R. Braathen, and H.-U. Simon Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment J Allergy Clin Immunol 114 2004 887 895 (Pubitemid 39330261)
11. S. Seidenari, and G. Giusti Objective assessment of the skin of children affected by atopic dermatitis: A study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin Acta Derm Venereol 75 1995 429 433 (Pubitemid 26051887)
12. J. Gupta, E. Grube, M.B. Ericksen, M.D. Stevenson, A.W. Lucky, and A.P. Sheth et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity J Allergy Clin Immunol 121 2008 725 730.e2
13. I. Angelova-Fischer, A.-C. Mannheimer, A. Hinder, A. Ruether, A. Franke, and R.H.H. Neubert et al. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling Exp Dermatol 20 2011 351 356
14. P.G. Sator, J.B. Schmidt, and H. Honigsmann Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis J Am Acad Dermatol 48 2003 352 358 (Pubitemid 36337071)
15. E. Rodríguez, H. Baurecht, E. Herberich, S. Wagenpfeil, S.J. Brown, and H.J. Cordell et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease J Allergy Clin Immunol 123 2009 1361 1370.e7
16. C. Flohr, K. England, and S. Radulovic Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age Br J Dermatol 163 2010 1333 1336
17. M.C. Mihm Jr., N.A. Soter, H.F. Dvorak, and K.F. Austen The structure of normal skin and the morphology of atopic eczema J Invest Dermatol 67 1976 305 312
18. M. Suarez-Farinas, S.J. Tintle, A. Shemer, A. Chiricozzi, K. Nograles, and I. Cardinale et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities J Allergy Clin Immunol 127 2011 954 964 e1-4
19. S. Tintle, A. Shemer, M. Suarez-Farinas, H. Fujita, P. Gilleaudeau, and M. Sullivan-Whalen et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response J Allergy Clin Immunol 128 2011 583 584
20. E. Guttman-Yassky, M. Suarez-Farinas, A. Chiricozzi, K.E. Nograles, A. Shemer, and J. Fuentes-Duculan et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis J Allergy Clin Immunol 124 2009 1235 1244.e58
21. J.K. Gittler, J.G. Krueger, and E. Guttman-Yassky Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis J Allergy Clin Immunol 131 2013 300 313
22. J. van Smeden, M. Janssens, A.P. Lavrijsen, S. Kezic, R.J. Vreeken, and J.A. Bouwstra Skin barrier dysfunction in non-lesional atopic eczema: the role of stratum corneum lipids Eur J Dermatol 2013 [Epub ahead of print]
23. K. Eyerich, and N. Novak Immunology of atopic eczema: overcoming the Th1/Th2 paradigm Allergy 68 2013 974 982
24. J.B. Van Der Meer, E.J. Glazenburg, P.G. Mulder, H.F. Eggink, and P.J. Coenraads The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group Br J Dermatol 140 1999 1114 1121 (Pubitemid 29284586)
25. K.S. Thomas, S. Armstrong, A. Avery, A.L. Po, C. O'Neill, and S. Young et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema BMJ 324 2002 768
26. J. Hanifin, A.K. Gupta, and R. Rajagopalan Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients Br J Dermatol 147 2002 528 537 (Pubitemid 35015290)
27. J. Berth-Jones, R.J. Damstra, S. Golsch, J.K. Livden, O. Van Hooteghem, and F. Allegra et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study BMJ 326 2003 1367
28. M.E. Kirkup, N.M. Birchall, E.G. Weinberg, K. Helm, and C.T. Kennedy Acute and maintenance treatment of atopic dermatitis in children - two comparative studies with fluticasone propionate (0.05%) cream J Dermatolog Treat 14 2003 141 148 (Pubitemid 37254625)
29. A. Peserico, G. Stadtler, M. Sebastian, R.S. Fernandez, K. Vick, and T. Bieber Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: A multicentre, randomized, double-blind, controlled study Br J Dermatol 158 2008 801 807 (Pubitemid 351415740)
30. E.J. Glazenburg, A. Wolkerstorfer, A.L. Gerretsen, P.G. Mulder, and A.P. Oranje Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls? Pediatr Allergy Immunol 20 2009 59 66
31. A.S. Paller, L.F. Eichenfield, R.S. Kirsner, T. Shull, E. Jaracz, and E.L. Simpson Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: A new paradigm for use Pediatrics 122 2008 e1210 e1218
32. D. Breneman, A.B. Fleischer Jr., W. Abramovits, J. Zeichner, M.H. Gold, and R.S. Kirsner et al. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle J Am Acad Dermatol 58 2008 990 999
33. A. Wollenberg, S. Reitamo, F. Atzori, M. Lahfa, T. Ruzicka, and E. Healy et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment Allergy 63 2008 742 750
34. M. Meurer, M. Fartasch, G. Albrecht, T. Vogt, M. Worm, and T. Ruzicka et al. Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis Dermatology 208 2004 365 372 (Pubitemid 38736667)
35. M. Ruer-Mulard, W. Aberer, A. Gunstone, O.M. Kekki, J.L. Lopez Estebaranz, and A. Vertruyen et al. Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis Pediatr Dermatol 26 2009 551 558
36. D. Thaci, S. Reitamo, M.A. Gonzalez Ensenat, C. Moss, V. Boccaletti, and T. Cainelli et al. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study Br J Dermatol 159 2008 1348 1356
37. M. Meurer, L.F. Eichenfield, V. Ho, P.C. Potter, T. Werfel, and T. Hultsch Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: A randomized, double-blind trial J Dermatolog Treat 21 2010 157 166
38. J.I. Harper, I. Ahmed, G. Barclay, M. Lacour, P. Hoeger, and M.J. Cork et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy Br J Dermatol 142 2000 52 58 (Pubitemid 30074470)
39. S. Tzaneva, H. Kittler, G. Holzer, D. Reljic, M. Weber, and H. Honigsmann et al. 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: A randomized crossover trial Br J Dermatol 162 2010 655 660
40. H. Granlund, P. Erkko, M. Sinisalo, and S. Reitamo Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy Br J Dermatol 132 1995 106 112
41. H.W. Williams, and B The natural history of atopic dermatitis 2000 Cambridge University Press West Nyack (NY)
42. J. Schmitt, P. Spuls, M. Boers, K. Thomas, J. Chalmers, and E. Roekevisch et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting Allergy 67 2012 1111 1117
43. T. Goto, Y. Soma, C. Ra, Y. Kawa, Y. Kubota, and M. Mizoguchi Enhanced expression of the high-affinity receptor for IgE (Fc(epsilon)RI) associated with decreased numbers of Langerhans cells in the lesional epidermis of atopic dermatitis J Dermatol Sci 27 2001 156 161 (Pubitemid 32964687)
44. K.H. Kim, J.H. Han, J.H. Chung, K.H. Cho, and H.C. Eun Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes J Korean Med Sci 21 2006 315 323
45. W. Owczarek, M. Paplinska, T. Targowski, K. Jahnz-Rozyk, E. Paluchowska, and A. Kucharczyk et al. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis Cytokine 50 2010 181 185
46. D. Simon, R.L. Lindberg, E. Kozlowski, R.L. Braathen, and H.U. Simon Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions Exp Dermatol 15 2006 441 446
47. E. Sonkoly, A. Muller, A.I. Lauerma, A. Pivarcsi, H. Soto, and L. Kemeny et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation J Allergy Clin Immunol 117 2006 411 417 (Pubitemid 43192023)
48. M. Suarez-Farinas, S.J. Tintle, A. Shemer, A. Chiricozzi, K. Nograles, and I. Cardinale et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities J Allergy Clin Immunol 127 2011 954 964 e1-4
49. I. Van der Ploeg, M. Jeddi Tehrani, G. Matuseviciene, C.F. Wahlgren, J. Fransson, and A. Schevnius IL-13 over-expression in skin is not confined to IgE-mediated skin inflammation Clin Exp Immunol 109 1997 526 532 (Pubitemid 27402323)
50. A. Wollenberg, S. Wen, and T. Bieber Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod Cytometry 37 1999 147 155 (Pubitemid 29463484)
51. N. Yawalkar, S. Schmid, L.R. Braathen, and W.J. Pichler Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis Br J Dermatol 144 2001 1133 1139 (Pubitemid 34204202)
52. N. Yawalkar, M. Uguccioni, J. Scharer, J. Braunwalder, S. Karlen, and B. Dewald et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis J Invest Dermatol 113 1999 43 48 (Pubitemid 29328157)
53. C.J. Broccardo, S. Mahaffey, J. Schwarz, L. Wruck, G. David, and P.M. Schlievert et al. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization J Allergy Clin Immunol 127 2011 186 193 e1-11
54. R. Voegeli, A.V. Rawlings, M. Breternitz, S. Doppler, T. Schreier, and J.W. Fluhr et al. Increased stratum corneum serine protease activity in acute eczematous atopic skin Br J Dermatol 161 2009 70 77
55. M. Yamamoto, Y. Kamata, T. Iida, H. Fukushima, J. Nomura, and M. Saito et al. Quantification of activated and total caspase-14 with newly developed ELISA systems in normal and atopic skin J Dermatol Sci 61 2011 110 117
56. C. Mathay, M. Pierre, M.R. Pittelkow, E. Depiereux, A.F. Nikkels, and A. Colige et al. Transcriptional profiling after lipid raft disruption in keratinocytes identifies critical mediators of atopic dermatitis pathways J Invest Dermatol 131 2011 46 58
57. S. Seidenari, and G. Giusti Objective assessment of the skin of children affected by atopic dermatitis: A study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin Acta Derm Venereol 75 1995 429 433 (Pubitemid 26051887)
58. S. Asano, Y. Ichikawa, T. Kumagai, M. Kawashima, and G. Imokawa Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis Br J Dermatol 159 2008 97 104 (Pubitemid 351874497)
59. N. Ballardini, C. Johansson, G. Lilja, M. Lindh, Y. Linde, and A. Scheynius et al. Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema Br J Dermatol 161 2009 40 47
60. A. Kedzierska, M. Kaprinska-Mrowiecka, M. Czubak-Macugowska, K. Wojcik, and J. Kedzierska Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization Br J Dermatol 159 2008 1290 1299
61. A. Danczak-Pazdrowska, A. Polanska, W. Sliny, A. Sadowska, A. Osmola-Mankowska, and M. Czarnecka-Operacz et al. Seemingly healthy skin in atopic dermatitis: observations with the use of high-frequency ultrasonography, preliminary study Skin Res Technol 18 2012 162 167
62. F. Pfab, M. Valet, T. Sprenger, J. Huss-Marp, G.I. Athanasiadis, and H.J. Baurecht et al. Temperature modulated histamine-itch in lesional and nonlesional skin in atopic eczema - a combined psychophysical and neuroimaging study Allergy 65 2010 84 94
63. A.D. Papoiu, H. Wang, L. Nattkemper, H.L. Tey, Y. Ishiuji, and Y.H. Chan et al. A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects Neuropeptides 45 2011 417 422
64. M. Ozawa, K. Tsuchiyama, R. Gomi, F. Kurosaki, Y. Kawamoto, and S. Aiba Neuroselective transcutaneous electrical stimulation reveals neuronal sensitization in atopic dermatitis J Am Acad Dermatol 60 2009 609 614
65. C. Bangert, B.E. Strober, M. Cork, J.P. Ortonne, T. Luger, and T. Bieber et al. Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: A randomized controlled trial Dermatology 222 2011 36 48
66. M. Caproni, D. Torchia, E. Antiga, M. Terranova, W. Volpi, and E. del Bianco et al. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: An immunohistochemical study Br J Dermatol 156 2007 312 319 (Pubitemid 46095960)
67. D. Simon, E. Vassina, S. Yousefi, E. Kozlowski, L.R. Braathen, and H.U. Simon Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment J Allergy Clin Immunol 114 2004 887 895 (Pubitemid 39330261)
68. S. Tintle, A. Shemer, M. Suarez-Farinas, H. Fujita, P. Gilleaudeau, and M. Sullivan-Whalen et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response J Allergy Clin Immunol 128 2011 583 593 e1-4